Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sarrecchia

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Immunology|September 30, 2000
Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanismsA Bergamini, F Bolacchi, B Bongiovanni, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|May 1, 1982
[Antibody response to trivalent anti-influenza vaccination (inactivated virus) A/Texas/1/77 H3N2), A/URSS/90/77 (H1N1), B/Hong Kong/8/73]G Mancini, M Andreoni, G Arangio-Ruiz, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|May 1, 1982
[Antibody response to an anti-influenza vaccine of inactivated whole virus, titrated in micrograms, used in the 1980/81 season]G Mancini, C Sarrecchia, I Donatelli, et al.
Infection|June 16, 2011
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistanceC Sarrecchia, V Svicher, A Volpi, et al.
Antiviral Research|September 17, 2011
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugsR Salpini, V Svicher, V Cento, et al.
Journal of Medical Virology|April 17, 2013
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practiceR Salpini, C Alteri, V Cento, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2015
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levelsV C Di Maio, V Cento, D Di Paolo, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Immunology|September 30, 2000
Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanismsA Bergamini, F Bolacchi, B Bongiovanni, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|May 1, 1982
[Antibody response to trivalent anti-influenza vaccination (inactivated virus) A/Texas/1/77 H3N2), A/URSS/90/77 (H1N1), B/Hong Kong/8/73]G Mancini, M Andreoni, G Arangio-Ruiz, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|May 1, 1982
[Antibody response to an anti-influenza vaccine of inactivated whole virus, titrated in micrograms, used in the 1980/81 season]G Mancini, C Sarrecchia, I Donatelli, et al.
Infection|June 16, 2011
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistanceC Sarrecchia, V Svicher, A Volpi, et al.
Antiviral Research|September 17, 2011
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugsR Salpini, V Svicher, V Cento, et al.
Journal of Medical Virology|April 17, 2013
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practiceR Salpini, C Alteri, V Cento, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2015
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levelsV C Di Maio, V Cento, D Di Paolo, et al.
Pageof 2